Sex Differences in LDL-C Reduction Response to Evolocumab: A Propensity Score Matching Analysis.

Ye-Qian He, Yu-Qing Wei, Guang-Ming Huang, Guo-Ping Liu,Zhong-Qiu Lin,Tao-Tao Liu,Xia Jiang,Jie-Jiu Lu

PHARMACOTHERAPY（2024）

Cited 0|Views4

Key words

cardiovascular risk,evolocumab,LDL-C,PCSK9i,sex differences

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined